Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
about
Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern FranceLead exposure and tremor among older men: the VA Normative Aging StudyStronger is not always better: could a bodybuilding dietary supplement lead to ALS?A comprehensive review of amyotrophic lateral sclerosisThinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signalingThe cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosisAnalytical techniques for the detection of α-amino-β-methylaminopropionic acidSearching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programmeEquilibrium Dynamics of β-N-Methylamino-L-Alanine (BMAA) and Its Carbamate Adducts at Physiological ConditionsConsiderations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiologyNatural toxins implicated in the development of Parkinson's disease.A comparative study on three analytical methods for the determination of the neurotoxin BMAA in cyanobacteriaThe epidemiology of ALS: a conspiracy of genes, environment and time.Amyotrophic lateral sclerosis in Piedmont (Italy): a Bayesian spatial analysis of the incident cases.Evaluation of a commercial enzyme linked immunosorbent assay (ELISA) for the determination of the neurotoxin BMAA in surface watersAmyotrophic lateral sclerosis: one or multiple causes?β-N-methylamino-L-alanine induces neurological deficits and shortened life span in DrosophilaHuman gut microbiota: the links with dementia developmentCo-occurrence of the cyanotoxins BMAA, DABA and anatoxin-a in Nebraska reservoirs, fish, and aquatic plantsPresence of the neurotoxin BMAA in aquatic ecosystems: what do we really know?Does α-amino-β-methylaminopropionic acid (BMAA) play a role in neurodegeneration?Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases?Peer recommendations on how to improve clinical research, and Conference wrap-up.MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.ALS and FTD: an epigenetic perspective.Overview of the potent cyanobacterial neurotoxin β-methylamino-L-alanine (BMAA) and its analytical determination.A Collaborative Evaluation of LC-MS/MS Based Methods for BMAA Analysis: Soluble Bound BMAA Found to Be an Important Fraction.Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of L-Serine.Grazing livestock are exposed to terrestrial cyanobacteria.Spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997-2009.Exposure to BMAA mirrors molecular processes linked to neurodegenerative disease.Metabolic profiling of zebrafish (Danio rerio) embryos by NMR spectroscopy reveals multifaceted toxicity of β-methylamino-L-alanine (BMAA).Cytotoxic Effects of Environmental Toxins on Human Glial Cells.Mechanisms of L-Serine Neuroprotection in vitro Include ER Proteostasis Regulation.L-Serine-Mediated Neuroprotection Includes the Upregulation of the ER Stress Chaperone Protein Disulfide Isomerase (PDI).A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.Detection of the Cyanotoxins L-BMAA Uptake and Accumulation in Primary Neurons and Astrocytes.Methods for the Chemical Analysis of β-N-Methylamino-L-A lanine: What Is Known and What Remains to Be Determined.
P2860
Q21132388-C192979F-EE4F-4569-8E71-E20F0E5CC7FDQ23915303-E0DF705D-DA84-42EB-A68C-F68DDB2EBED3Q24607879-ACB90C8A-BD15-4003-9ECF-A67F8CD0081BQ26775401-A06A9C67-57B6-450B-AD51-3F3CBCBC90B2Q26864995-3888CA47-8AC8-4B29-9939-FD19B5994353Q26999594-997CD5E4-3CAE-4CEA-A89E-5F0D00423A56Q28261995-CBD7C61E-25C5-4FB9-B2B1-BEFD6511D740Q28393837-EE795056-9C9C-4A26-99EB-B7EC5B4EDA51Q28553466-A4544431-D410-4D66-A239-D56A7CE1B5F0Q33603777-DEC4BFE6-74E7-4DFC-B33F-CFE7BC4B88A8Q34029794-DB4BA700-5A73-4BFE-B4BE-C1C1258015ECQ34263391-5CC12964-B785-4200-927A-1D7E454851CDQ34377698-BAC28997-938B-4301-BF9A-EB673B14288FQ34470118-97E6F903-3911-4CDE-9C90-FF0D5BC15BDCQ34769760-F3B61D84-8BCC-4084-BD9D-C8C5C61AC99CQ35120449-F69E71A6-7337-48AD-9ADD-A9FD9C2F0A46Q35155641-E558B2B3-07A4-40FC-9B10-1F98893A9068Q36198753-D62953AE-0007-4852-B6DE-8BB4EA55C283Q37617784-EE3981AE-3701-4DFF-91E9-07B6254BDDACQ37670046-3E750031-F193-474D-B3B6-30F8BAD4095AQ37948045-4FDE48C6-5631-4ED0-8529-737012D02E29Q37972904-D2F981CC-8453-4B13-A8F1-3BDBFE6A0F4CQ38071378-1C06F19D-86D6-49BD-979B-59A3E06F60A1Q38107221-01BB9A16-2881-4B27-B8F4-EB8267458A2FQ38272668-95320D31-F8F6-4AAC-BE1C-E4ED127C340AQ38734183-5528E0F2-B5DD-4A60-95BE-24B3C12F8D3CQ38860456-D6FC2370-D492-4B58-819B-8ADEF2D7795EQ38960608-9936322E-B9F5-4C44-A3A6-C3CD0DAA6EE9Q39855552-545C638C-7CCE-49EE-BAA1-BEE91766F1FBQ40193214-D3229E6F-633E-4016-935B-11C2870E7D0AQ41366095-5AF68C8F-0F21-4E5D-879A-E7EBEDA0B0BDQ44109735-FE72AB10-50BE-4BC9-A97B-4C9CF8A82599Q44874945-AD869205-0061-4BF9-A1B6-8B7536772898Q46243379-304FBC74-69B0-412A-8896-A9B6C9676B6FQ46467372-394E4E40-0B3A-447A-AD25-934D902F123CQ47446276-9D48E4CD-D13F-459C-8059-19E12D02BD10Q47702520-D9B53FDE-F4A9-4C87-A9BE-9FB24C66EC28Q47891276-E8C9B273-7434-4FDD-93C0-BF7C011C34F2Q48134620-CAC05BA9-AF4E-4FFE-B1F3-32BD47EC59D0Q48188267-27F00EB8-526C-43D8-A4D5-86238989452C
P2860
Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@ast
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@en
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@nl
type
label
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@ast
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@en
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@nl
prefLabel
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@ast
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@en
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@nl
P2860
P921
P1476
Beyond Guam: the cyanobacteria ...... er neurodegenerative diseases.
@en
P2093
Deborah C Mash
Walter G Bradley
P2860
P356
10.3109/17482960903286009
P478
10 Suppl 2
P577
2009-01-01T00:00:00Z